Y-mAbs' Private Equity - II Round

Y-mAbs raised a round of funding on November 29, 2017.

YmAbs (NASDAQ: YMAB) is a clinical-stage biopharmaceutical company developing antibody therapeutics for oncology targets based on a range of technologies licensed from Memorial Sloan Kettering Cancer …

Articles about Y-mAbs' Private Equity - II Round: